Clinical trial
Prospective Study of Prednisone Versus Sirolimus in the Treatment of Idiopathic Retroperitoneal Fibrosis
NCT04047576 is registered in ClinicalTrials.gov with Peking University International Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Prednisone Versus Sirolimus in the Treatment of Idiopathic Retroperitoneal Fibrosis
- Lead sponsor
- Peking University International Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- June 28, 2026
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.